Skip to content

Calculus CEO John Glencross featured in the Sunday Times

Calculus Capital CEO John Glencross, alongside 11 other business and political leaders, has signed an open letter which has been published in the Sunday Times. The letter warns of the risks of making too many changes to EIS rules as part of the Patient Capital Review. The results of the review, and any changes, are … Continued

Weedingtech featured in the Guardian

Weedingtech has been featured in a Guardian article which discusses moves being made by the EU to potentially phase out the use of the herbicide Glyphosate over the next 5 years. The majority of Herbicides sold in the UK are Glyphosate based. Weedingtech offers an clean alternative which is focused on replacing toxic herbicides. They … Continued

Calculus VCT – Open for Investment

Calculus Capital launches VCT fundraising – providing exposure to diverse portfolio of entrepreneurial growth companies Calculus Capital has launched fundraising for the Calculus VCT, which aims to deliver investors an annual dividend of 4.5% (equating to 6.1% for investors who receive 30% income tax relief) and capital growth. The proceeds from the fundraising will be used … Continued

Benito’s Hat appoints new Managing Director

Benito’s Hat has been featured in City AM having appointed Michael Pearson as Managing Director following the decision of founder and CEO, Ben Fordham, to move to Texas. The founder and CEO of London food chain Benito’s Hat is handing over the reins to a new managing director as he jets off to try his … Continued

Cornerstone CEO Oliver Bridge Interviewed

Cornerstone CEO Oliver Bridge has been interviewed for a feature in Elite Business. For a link to the article click here. “It’s not often that the queue at Boots is credited for sparking entrepreneurial creativity. However, standing in line to buy a razor would change Oliver Bridge’s life forever. “It was all a bunch of rubbish,” … Continued

Synpromics wins ‘best emerging UK synthetic biotech company’ at OBN Awards

Synpromics has been awarded Best Emerging UK Synthetic Biotech Company at the 9th Annual OBN Awards celebration. “Synpromics was nominated on the strength of being the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data-driven design.” The OBN Awards celebrate innovation and outstanding achievement across … Continued

Once Upon A Time acquires MJ Media

Calculus portfolio company, Once Upon A Time, has acquired youth, entertainment and technology media specialist MJ Media. MJ Media is Once Upon a Time’s fourth acquisition, representing a keen commitment to the future growth strategy of the firm. Once Upon A Time provides an independent, integrated customer experience encompassing advertising, online media and in-store activities. … Continued